Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Immunoglobulin Light-chain Amyloidosis
×
Thalidomide
×
Clear all
Filters
3
NCT02545907
2021-04-15
CATALYST
University College, London
Phase 1/2
Completed
10 enrolled
14 charts